Skip Navigation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (6)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Hashimoto, Y.
Right arrow Articles by Matsuki, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hashimoto, Y.
Right arrow Articles by Matsuki, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

British Journal of Anaesthesia, 2000, Vol. 85, No. 3 460-462
© 2000 The Board of Management and Trustees of the British Journal of Anaesthesia

Spasmolytic effects of prostaglandin E1 on serotonin-induced bronchoconstriction and pulmonary hypertension in dogs

Y. Hashimoto, K. Hirota, H. Yoshioka, E. Hashiba, T. Kudo, H. Ishihara and A. Matsuki

Department of Anesthesiology, University of Hirosaki School of Medicine, Hirosaki 036–8562, Japan*Corresponding author

In this study, we simultaneously evaluated the spasmolytic effects of prostaglandin E1 (PGE1) on serotonin-induced bronchoconstriction and pulmonary hypertension. Eleven mongrel dogs (8–12 kg) anaesthetized with pentobarbital were assigned to two groups: saline (n=4) and PGE1 (n=7). Bronchoconstriction and pulmonary hypertension were elicited with serotonin 10 µg kg–1 + 1 mg kg–1 h–1 and assessed as the percentage change in bronchial cross-sectional area (BCA) measured by bronchoscopy and pulmonary vascular resistance (PVR), respectively. Thirty minutes after starting the serotonin infusion, saline or PGE1 0 (saline), 0.01, 0.1, 1.0 or 10 µg kg–1 i.v. was given. %BCA and %PVR (basal=100%) were assessed before and 30 min after serotonin, and 30 and 60 min after saline (saline group) or 5 min after each dose of PGE1 (PGE1 group). In the saline group, pulmonary hypertension and bronchoconstriction were stable. In the PGE1 group, PGE1 at >=0.1 µg kg–1 significantly decreased %BCA and 10 µg kg–1 almost fully reversed the constriction (from mean (SEM) 56.2% (4.9%) to 94.4% (3.7%)). %PVR was significantly decreased at 10 µg kg–1 (from 230% (24%) to 176% (11%)) only. We suggest that PGE1 may produce bronchodilation rather than pulmonary vasodilation.

Br J Anaesth 2000; 85: 460–2


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Br J AnaesthHome page
S. Kabara, K. Hirota, H. Yoshioka, T. Kudo, H. Ishihara, and A. Matsuki
Differential effects of thiopental on methacholine- and serotonin-induced bronchoconstriction in dogs{dagger}
Br. J. Anaesth., September 1, 2003; 91(3): 379 - 384.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
Z.'i. Wajima, T. Shiga, T. Yoshikawa, A. Ogura, K. Imanaga, T. Inoue, and R. Ogawa
Intravenous Alprostadil, an Analog of Prostaglandin E1, Prevents Thiamylal-Fentanyl-Induced Bronchoconstriction in Humans
Anesth. Analg., August 1, 2003; 97(2): 456 - 460.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
Y. Hashimoto, K. Hirota, H. Yoshioka, T. Kudo, H. Ishihara, and A. Matsuki
A Comparison of the Spasmolytic Effects of Olprinone and Aminophylline on Serotonin-Induced Pulmonary Hypertension and Bronchoconstriction With or Without {beta}-Blockade in Dogs
Anesth. Analg., December 1, 2000; 91(6): 1345 - 1350.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.